Ingrid Choong - Belmont CA, US Matthew Burdett - Belmont CA, US Warren DeLano - San Carlos CA, US Daniel Erlanson - San Francisco CA, US Dennis Lee - Swarthmore PA, US Willard Lew - San Mateo CA, US
Assignee:
Sunesis Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A61K031/38 C07D333/22
US Classification:
514448, 549 72
Abstract:
The present invention provides compounds having formula (I):.
Thienopyrimidines Useful As Aurora Kinase Inhibitors
Willard Lew - San Mateo CA, US Subramanian Baskaran - Foster City CA, US Johan D. Oslob - Sunnyvale CA, US Joshua C. Yoburn - San Francisco CA, US Min Zhong - Foster City CA, US
Assignee:
Sunesis Pharmaceuticals, Inc. - South San Francisco CA
International Classification:
A01N 43/90 A61K 31/519 C07D 491/00 C07D 495/00
US Classification:
5142601, 544278
Abstract:
The present invention provides compounds having the formula:.
Eda Canales - San Mateo CA, US Michael O'Neil Hanrahan Clarke - Redwood City CA, US Scott E. Lazerwith - San Francisco CA, US Willard Lew - San Mateo CA, US Philip Anthony Morganelli - Oakland CA, US William J. Watkins - Saratoga CA, US
Eda Canales - San Mateo CA, US Lee S. Chong - Newark CA, US Michael O' Neil Hanrahan Clarke - Redwood City CA, US Edward Doerffler - Union City CA, US Scott E. Lazerwith - San Francisco CA, US Willard Lew - San Mateo CA, US Michael Mertzman - Belmont CA, US Philip A. Morganelli - Oakland CA, US William J. Watkins - Saratoga CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
A01N 43/06 A61K 31/38
US Classification:
514447, 549 69
Abstract:
Provided are compounds of Formula I:.
2,4,6-Trisubstituted Pyrido(3,2-D)Pyrimidines Useful For Treating Viral Infections
Eda Canales - San Mateo CA, US Lee S. Chong - Newark CA, US Michael O' Neil Hanrahan Clarke - Redwood City CA, US Scott E. Lazerwith - San Francisco CA, US Willard Lew - San Mateo CA, US Qi Liu - Foster City CA, US Michael L. Mitchell - Hayward CA, US William J. Watkins - Saratoga CA, US Jennifer R. Zhang - Foster City CA, US
Assignee:
Gilead Sciences, Inc. - Foster City CA
International Classification:
A01N 43/90 A61K 31/519 C07D 487/00
US Classification:
51426411, 544279
Abstract:
Pyrido(3,2-d)pyrimidine derivatives represented by the structural formula (Ia): wherein, R, Rand Rare defined herein, pharmaceutical acceptable addition salts, stereochemical isomeric forms, N-oxides, solvates and pro-drugs thereof, for use in the treatment of hepatitis C.
Eda Canales - San Mateo CA, US Lee S. Chong - Newark CA, US Michael O'Neil Hanrahan Clarke - Redwood City CA, US Edward Doerffler - Union City CA, US Scott E. Lazerwith - San Francisco CA, US Willard Lew - San Mateo CA, US Qi Liu - Foster City CA, US Michael Mertzman - Belmont CA, US Philip A. Morganelli - Oakland CA, US William J. Watkins - Saratoga CA, US Hong Ye - Richmond CA, US
Norbert Bischofberger - San Carlos CA, US Terrence Dahl - Sunnyvale CA, US Michael Hitchcock - San Mateo CA, US Choung Kim - San Carlos CA, US Willard Lew - San Mateo CA, US Hongtao Liu - Foster City CA, US Roger Mills - Menlo Park CA, US Matthew Williams - Foster City CA, US
International Classification:
A61K031/655 A61K031/275 A61K031/215 A61K031/195
US Classification:
514/519000, 514/529000, 514/563000, 514/151000
Abstract:
Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.
Novel Compounds And Methods For Synthesis And Therapy
NORBERT W. BISCHOFBERGER - SAN CARLOS CA, US CHOUNG U. KIM - SAN CARLOS CA, US WILLARD LEW - SAN MATEO CA, US HONGTAO LIU - FOSTER CITY CA, US MATTHEW A. WILLIAMS - FOSTER CITY CA, US
International Classification:
A61K031/47
US Classification:
514310000
Abstract:
Novel compounds are described. The compounds generally comprise an acidic group, a basic group, a substituted amino or N-acyl and a group having an optionally hydroxylated alkane moiety. Pharmaceutical compositions comprising the inhibitors of the invention are also described. Methods of inhibiting neuraminidase in samples suspected of containing neuraminidase are also described. Antigenic materials, polymers, antibodies, conjugates of the compounds of the invention with labels, and assay methods for detecting neuraminidase activity are also described.